Biotec Pharmacon has today 11.05.2017 held the 2017 ordinary general meeting.
Please find enclosed the minutes from the general meeting
This information is subject of the disclosure requirements according to section
5-12 of the Norwegian Securities Trading Act.
For further information, please contact
Svein Lien, CEO
+47 922 89 323
svein.lien@biotec.no